GHTF (Global Harmonization Task Force) agrees to adding more representatives
This article was originally published in Clinica
Executive Summary
The recent meeting of the Global Harmonization Task Force Steering Committee meeting on May 18-20 devoted much time to the fine-tuning of the revision of its founding rules, as expected. No huge changes were made, but the committee decided that the chairing region may add two representatives as the chairman and vice-chairman may not be selected from amongst current SC members.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.